FDA Clears Wildtype’s Lab-Grown Salmon for Sale
_3.jpg)
The US Food and Drug Administration (FDA) has cleared cell-based seafood company Wildtype to market products, marking a first for the sector.
The agency issued a “no questions” letter following a pre-market consultation, confirming its agreement with the San-Francisco-based company’s assessment that its cultivated salmon is “safe” for consumption.
Wildtype’s production process begins with the procurement of source cells from fry-stage coho salmon (Oncorhynchus kisutch) raised in a hatchery in Washington state.
The viable cells are proliferated in stainless steel bioreactors using Wildtype’s...
To Read Full Story Login Below.